Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(27 sites)
United Kingdom
Buckinghamshire Healthcare NHS Trust, Aylesbury Belfast Health and Social Care Trust, Belfast Sandwell and West Birmingham Hospitals NHS Trust, Birmingham Bradford Teaching Hospitals NHS Foundation Trust, Bradford University Hospitals Bristol NHS Foundation Trust, Bristol County Durham and Darlington NHS Foundation Trust, Darlington NHS Greater Glasgow & Clyde, Glasgow Hull University Teaching Hospitals NHS Trust, Hull The Leeds Teaching Hospitals NHS Trust, Leeds University Hospitals Leicester NHS Trust, Leicester Liverpool University Hospitals NHS Foundation Trust, Liverpool Barts Health NHS Trust, London Guys & St Thomas NHS Foundation Trust, London King's College Hospital NHS Foundation Trust, London Moorfields Eye Hospital NHS Foundation Trust, London Manchester University NHS Foundation Trust, Manchester South Tees Hospitals NHS Foundation Trust, Middlesbrough Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals Plymouth NHS Trust, Plymouth Royal Berkshire NHS Foundation Trust, Reading Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield University Hospital Southampton NHS Foundation Trust, Southampton South Tyneside and Sunderland NHS Trust, Sunderland Mid & South Essex NHS Foundation Trust, Westcliff-on-Sea The Royal Wolverhampton NHS Trust, Wolverhampton York and Scarborough Teaching Hospitals NHS Foundation Trust, York